-
公开(公告)号:US20230174454A1
公开(公告)日:2023-06-08
申请号:US17998111
申请日:2021-05-10
Applicant: Genomatica, Inc.
Inventor: Bo CHEN , Iman SAFARI , Seth LEVINE
Abstract: A process for synthesizing (R)-3 -hy droxybutyl (R)-3 -hy droxybutanoate from ethyl (R)-3-hydroxybutanoate and (R)-1,3-butanediol, as well a process for synthesizing (R)-3-hy droxybutyl (R)-3-hy droxybutanoate from (R)-3-hydroxybutyric acid and (R)-1,3-butanediol. Also provided are processes for isolating (R)-3-hy droxybutyl (R)-3-hy droxybutanoate, including from a fermentation broth.
-
公开(公告)号:US20230136909A1
公开(公告)日:2023-05-04
申请号:US17833695
申请日:2022-06-06
Applicant: Genomatica, Inc.
Inventor: Anthony P. Burgard , Robin E. Osterhout , Stephen J. Van Dien , Cara Ann Tracewell , Priti Pharkya , Stefan Andrae
IPC: C12N15/52 , C12P7/42 , C08F120/06 , C08G63/664 , C12N15/63 , C12P7/24 , C12P7/40 , C12N9/04 , C12N9/06 , C12N9/10 , C12P7/62
Abstract: Provided herein is a non-naturally occurring microbial organism having a methanol metabolic pathway that can enhance the availability of reducing equivalents in the presence of methanol. Such reducing equivalents can be used to increase the product yield of organic compounds produced by the microbial organism, such as 3-hydroxyisobutyrate or MAA. Also provided herein are methods for using such an organism to produce 3-hydroxyisobutyrate or MAA.
-
公开(公告)号:US20230022583A1
公开(公告)日:2023-01-26
申请号:US17831011
申请日:2022-06-02
Applicant: Genomatica, Inc.
Inventor: Liang Wu , Axel Christoph Trefzer , Stefaan Marie Andre De Wildeman , Marco Alexander Van Den Berg
Abstract: The present invention relates to a method for preparing an adipate ester or thioester. The invention further relates to a method for preparing adipic acid from said ester or thioester. Further the invention provides a number of methods for preparing an intermediate for said ester or thioester. Further the invention relates to a method for preparing 6-amino caproic acid (6-ACA), a method for preparing 5-formyl valeric acid (5-FVA), and a method for preparing caprolactam. Further, the invention relates to a host cell for use in a method according to the invention.
-
公开(公告)号:US11535874B2
公开(公告)日:2022-12-27
申请号:US14436722
申请日:2013-10-21
Applicant: Genomatica, Inc.
Inventor: Anthony P. Burgard , Robin E. Osterhout , Stephen J. Van Dien , Cara Ann Tracewell , Priti Pharkya , Stefan Andrae
IPC: C12N9/96 , C12P7/46 , C12N9/04 , C12N9/06 , C12N9/10 , C07C55/10 , C08G63/00 , C12N15/70 , C12N15/81 , C12P7/24 , C07C59/235 , C12N15/74 , C12N15/77
Abstract: Provided herein is a non-naturally occurring microbial organism (NNOMO) having a methanol metabolic pathway (MMP) that can enhance the availability of reducing equivalents in the presence of methanol. Such reducing equivalents can be used to increase the product yield of organic compounds produced by the microbial organism, such as succinate. Also provided herein are methods for using such an organism to produce succinate.
-
公开(公告)号:US20220403420A1
公开(公告)日:2022-12-22
申请号:US17770233
申请日:2020-10-22
Applicant: Genomatica, Inc.
Inventor: Harish Nagarajan , Gionata Scalcinati , Tae Hoon Yang
Abstract: The present disclosure provides microbial organisms having increased availability of co-factors, such as NADPH, for increasing production of various products, including 1,3-BDO, MMA, (3R)-hydroxybutyl (3R)-hydroxybutyrate, amino acids, 3HB-CoA, adipate, caprolactam, 6-ACA, HMD A, or MAA, and products made from any of these. Also provided are one or more exogenous nucleic acids encoding an enzyme expressed in a sufficient amount to increase availability of NADPH, where the exogenous nucleic acid includes one or more of ATP-NADH kinase, pntAB, nadK, and gapN. Also provided are one or more gene attenuations occurring in genes, such as NDH-2, that result in an increased ratio of NADPH to NADH. Various combinations of the exogenous nucleic acids and gene deletions are also provided in the present disclosure. The present disclosure also provides methods of making and using the same, including methods for culturing cells, and for the production of the various products.
-
86.
公开(公告)号:US20220348932A1
公开(公告)日:2022-11-03
申请号:US17516424
申请日:2021-11-01
Applicant: Genomatica, Inc.
Inventor: Robin E. Osterhout , Anthony P. Burgard , Priti Pharkya , Stefan Andrae
Abstract: The invention provides non-naturally occurring microbial organisms having a formaldehyde fixation pathway, a formate assimilation pathway, and/or a methanol metabolic pathway in combination with a fatty alcohol, fatty aldehyde, fatty acid or isopropanol pathway, wherein the microbial organisms selectively produce a fatty alcohol, fatty aldehyde or fatty acid of a specified length or isopropanol. The microbial organisms provided advantageously enhance the production of substrates and/or pathway intermediates for the production of chain length specific fatty alcohols, fatty aldehydes, fatty acids or isopropanol. In some aspects, the microbial organisms of the invention have select gene disruptions or enzyme attenuations that increase production of fatty alcohols, fatty aldehydes or fatty acids. The invention additionally provides methods of using the above microbial organisms to produce a fatty alcohol, a fatty aldehyde, a fatty acid or isopropanol.
-
公开(公告)号:US11447804B2
公开(公告)日:2022-09-20
申请号:US16178432
申请日:2018-11-01
Applicant: Genomatica, Inc.
Inventor: Anthony P. Burgard , Robin E. Osterhout , Stephen J. Van Dien , Cara Ann Tracewell , Priti Pharkya , Stefan Andrae
IPC: C12P17/10 , C12P7/44 , C12P7/24 , C12P13/00 , C12N9/04 , C08G63/78 , C08G73/02 , C08G69/16 , C08G69/08 , A23L29/00 , C12N15/52
Abstract: Provided herein is a non-naturally occurring microbial organism having a methanol metabolic pathway that can enhance the availability of reducing equivalents in the presence of methanol. Such reducing equivalents can be used to increase the product yield of organic compounds produced by the microbial organism, such as adipate, 6-aminocaproate, hexamethylenediamine or caprolactam. Also provided herein are methods for using such an organism to produce adipate, 6-aminocaproate, hexamethylenediamine or caprolactam.
-
公开(公告)号:US11434512B2
公开(公告)日:2022-09-06
申请号:US16234315
申请日:2018-12-27
Applicant: GENOMATICA, INC.
Inventor: Fernando Sanchez-Riera , Stephen Del Cardayre , Fernando Valle
IPC: C12P7/64 , C12P7/06 , C12N1/21 , C12N1/19 , C12N9/18 , C12N9/00 , C12N9/10 , C12P7/649 , C12N9/02 , C12N9/52 , C12N9/04
Abstract: Methods of producing fatty acid esters, such as fatty acid ethyl esters, from genetically engineered microorganisms are described.
-
公开(公告)号:US11421206B2
公开(公告)日:2022-08-23
申请号:US16661667
申请日:2019-10-23
Applicant: Genomatica, Inc.
Inventor: Baolong Zhu , Andreas W. Schirmer , Cindy Chang
IPC: C12N9/02 , C12N15/62 , C12P7/6409
Abstract: The disclosure relates to omega-hydroxylase-related fusion polypeptides that result in improved omega-hydroxylated fatty acid derivative production when expressed in recombinant host cells. The disclosure further relates to microorganisms for expressing the omega-hydroxylase-related fusion polypeptides for the production of omega-hydroxylated fatty acid derivatives.
-
公开(公告)号:US20220235385A1
公开(公告)日:2022-07-28
申请号:US17605196
申请日:2020-04-24
Applicant: Genomatica, Inc.
Inventor: Amit M. Shah , Harish Nagarajan
Abstract: Disclosed are biosynthetic methods and engineered microorganism that enhance or improve the biosynthesis of hexamethylenediamine, caproic acid or caprolactam. The engineered microorganisms include selected aldehyde dehydrogenase activity.
-
-
-
-
-
-
-
-
-